Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William G Kaelin

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Cancer|April 30, 2009
Treatment of kidney cancer: insights provided by the VHL tumor-suppressor proteinWilliam G Kaelin
Annals of the New York Academy of Sciences|October 27, 2010
New cancer targets emerging from studies of the Von Hippel-Lindau tumor suppressor proteinWilliam G Kaelin
Annual Review of Biochemistry|June 15, 2005
Proline hydroxylation and gene expressionWilliam G Kaelin
Cell Metabolism|August 2, 2005
ROS: really involved in oxygen sensingWilliam G Kaelin
Cancer Cell|December 9, 2008
Kidney cancer: now available in a new flavorWilliam G Kaelin
The Journal of Clinical Investigation|September 15, 2022
Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancerWilliam G Kaelin
Genome Medicine|October 30, 2009
Synthetic lethality: a framework for the development of wiser cancer therapeuticsWilliam G Kaelin
Nature Reviews. Cancer|September 5, 2002
Molecular basis of the VHL hereditary cancer syndromeWilliam G Kaelin
Journal of the American Society of Nephrology : JASN|October 22, 2003
The von Hippel-Lindau gene, kidney cancer, and oxygen sensingWilliam G Kaelin
Cancer Biology & Therapy|September 26, 2003
E2F1 as a target: promoter-driven suicide and small molecule modulatorsWilliam G Kaelin
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Cancer|April 30, 2009
Treatment of kidney cancer: insights provided by the VHL tumor-suppressor proteinWilliam G Kaelin
Annals of the New York Academy of Sciences|October 27, 2010
New cancer targets emerging from studies of the Von Hippel-Lindau tumor suppressor proteinWilliam G Kaelin
Annual Review of Biochemistry|June 15, 2005
Proline hydroxylation and gene expressionWilliam G Kaelin
Cell Metabolism|August 2, 2005
ROS: really involved in oxygen sensingWilliam G Kaelin
Cancer Cell|December 9, 2008
Kidney cancer: now available in a new flavorWilliam G Kaelin
The Journal of Clinical Investigation|September 15, 2022
Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancerWilliam G Kaelin
Genome Medicine|October 30, 2009
Synthetic lethality: a framework for the development of wiser cancer therapeuticsWilliam G Kaelin
Nature Reviews. Cancer|September 5, 2002
Molecular basis of the VHL hereditary cancer syndromeWilliam G Kaelin
Journal of the American Society of Nephrology : JASN|October 22, 2003
The von Hippel-Lindau gene, kidney cancer, and oxygen sensingWilliam G Kaelin
Cancer Biology & Therapy|September 26, 2003
E2F1 as a target: promoter-driven suicide and small molecule modulatorsWilliam G Kaelin
Pageof 16